Medtronic Files Form 425 Website Materials for MiniMed Group Exchange Offer

Executive Summary

On October 6, 2026, Medtronic plc filed a Form 425 submission under Rule 425 of the Securities Act of 1933 (Commission File No. 001-36820). The filing provides documentation and disclosure regarding the communication materials hosted on the transaction website (https://www.dfking.com/MDTSeparation).

Transaction Details

• Nature of Filing: Prospectus/tender offer communication pursuant to Rule 425.
• Transaction Scope: Medtronic's offer to exchange up to an aggregate of 225,361,295 newly issued shares of common stock of MiniMed Group, Inc. owned by Medtronic for outstanding common shares of Medtronic.
• Information Agent: D.F. King & Co., Inc.
• Insider Activity: N/A. This is a corporate reorganization/separation exchange offer disclosure, not an individual officer or director transaction report.

Market Impact & Significance

• Trading Significance: Low in terms of insider sentiment tracking, as no insider equity transactions occurred.
• Strategic Relevance: Significant corporate restructuring update regarding the corporate separation of MiniMed Group, Inc., providing participating shareholders details on exchange ratios, pricing, and tender deadlines.